WuXi Biologics (Cayman) Inc. (WXIBF)
| Previous close | 1.8200 |
| Open | 1.6960 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 1.6960 - 1.6960 |
| 52-week range | 1.6300 - 6.6000 |
| Volume | |
| Avg. volume | 23,400 |
| Market cap | 7.052B |
| Beta (5Y monthly) | 0.63 |
| PE ratio (TTM) | 15.42 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- South China Morning Post
US House committee moves quickly to approve bill limiting business with Chinese biotech firms
Bipartisan legislation that would restrict US business with world-leading Chinese biotech companies and their subsidiaries was approved by a House of Representatives committee on Wednesday. The House Committee on Oversight and Accountability passed the bill 40-1. To become law, the bill must pass the full House and Senate, then be signed by the president. The bill, introduced on Friday, would prevent federal agencies from contracting with five Chinese biotech companies - BGI Group, MGI, Complete
- Yahoo Finance
AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain'
AstraZeneca CEO Pascal Soriot joined Yahoo Finance to discuss the company's earnings today.
- South China Morning Post
US lawmaker moves bill to ban Chinese biotech firms from federal contracts, alleging complicity with military
A US lawmaker has proposed a bill to block Chinese biotechnology companies doing business with the US government due to alleged complicity with the Chinese military, broadening the ongoing sanctions in sectors including hi-tech, semiconductors and cotton production over economic, political and human rights issues. China seeks to dominate biotechnology as an industry of the future, and the nation's biotech firms "have repeatedly collaborated with PLA [the People's Liberation Army] entities" with
